GeneFluidics, Inc.

Irwindale, CA · Medtech · Private

NicuMax®, an in vitro diagnostic (IVD) device for rapid bacterial identification and antimicrobial susceptibility testing in neonatal blood cultures

Grants
$9.8M
8 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$60K
4 awards · Veterans Affairs
#562 of 4531 in medtech
Patents
19
3 granted · 16 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Veterans Affairs · System Upgrade Package:$15,000
Federal contractDepartment of Veterans Affairs · Small Purchase Data$24,875
Federal contractDepartment of Veterans Affairs · Small Purchase Data$20,000
Federal grantDepartment of Health and Human Services · Phase II · An antibiogram-based CentriCapillary system for neonatal sepsis PID and AST$224,468
Federal grantDepartment of Health and Human Services · Phase I · Promote HPV screening rate with a non-invasive HPV POC cartridge$223,629
Federal grantDepartment of Health and Human Services · Phase II · An antibiogram-based CentriCapillary system for neonatal sepsis PID and AST$747,722
Federal grantDepartment of Health and Human Services · Phase II · Near patient molecular diagnostics test for infections$2,989,569
Federal grantDepartment of Health and Human Services · Phase II · An antibiogram-based CentriCapillary system for neonatal sepsis PID and AST$747,857
Federal grantDepartment of Health and Human Services · Phase II · Safe and Effective Whole Blood ID/AST Device for Use in Neonatal ICU Settings$2,893,556
Federal grantDepartment of Health and Human Services · Phase II · Safe and Effective Whole Blood ID/AST Device for Use in Neonatal ICU Settings$964,308
Federal grantDepartment of Health and Human Services · Phase II · Safe and Effective Whole Blood ID/AST Device for Use in Neonatal ICU Settings$962,488
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
559Global Cooling, Inc.$61K$3.2M
560Cytocybernetics$61K—
561O.N. DIAGNOSTICS, LLC$61K—
562GeneFluidics, Inc.$60K—
563MITEGEN, LLC$60K—
564CELLEX, INC.$58K—
565VivoSense, Inc.$53K$12M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 19
  • Specimen Collection For Microbial Burden Classification And Specimen Transportation To Lab For Reporting Direct-from-specimen Id And Astapplication
  • Phenotypic Antimicrobial Susceptibility Profiling Of Unidentified Pathogens Directly From Patient Samplesapplication
  • Generation Of Data For Use With Antimicrobialsgranted
  • Generation Of Data For Use With Antimicrobialsapplication
  • Generation Of Data For Use With Antimicrobialsapplication
  • Cartridge For Liquid Transportgranted
  • Sample Dependent Selection Of Parameters For Use In Electrokinetic Treatment Of The Samplegranted
  • Electrokinetic Polymerase Chain Reaction (pcr) Devices And Methodsapplication
  • Generation Of Data For Use With Antimicrobialsapplication
  • Specimen Collection For Microbial Burden Classification And Specimen Transportation To Lab For Reporting Direct-from-specimen Id And Astapplication
  • Sample Dependent Selection Of Parameters For Use In Electrokinetic Treatment Of The Sampleapplication
  • Cartridge For Liquid Transportapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.